NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP), the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that Company executives are scheduled to present a corporate update at the BIO CEO & Investor Conference on Tuesday, February 15, 2011 at 10am ET at the Waldorf-Astoria Hotel in New York City.
